University of California San Francisco, Division of Endocrinology and Metabolism — San Francisco, California

University of California San Francisco, Division of Endocrinology and Metabolism is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of California San Francisco, Division of Endocrinology and Metabolism has participated in 5 clinical trials.

Therapeutic areas: Fibrodysplasia Ossificans Progressiva.

Sponsors: Clementia Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Francisco, Division of Endocrinology and Metabolism?

University of California San Francisco, Division of Endocrinology and Metabolism has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Francisco, Division of Endocrinology and Metabolism conducted?

University of California San Francisco, Division of Endocrinology and Metabolism has 5 clinical trials on record. Their work covers Fibrodysplasia Ossificans Progressiva.

Is University of California San Francisco, Division of Endocrinology and Metabolism accredited by Crixeo Health?

University of California San Francisco, Division of Endocrinology and Metabolism has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Francisco, Division of Endocrinology and Metabolism?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.